West Pharmaceutical Services Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $791.3M | $484.6M | $853.9M | $894.3M | $762.6M | $615.5M | $439.1M | $337.4M |
| Accounts Receivable | $574.4M | $552.5M | $512.0M | $507.4M | $489.0M | $385.3M | $319.3M | $288.2M |
| Inventory | $443.9M | $377.0M | $434.7M | $414.8M | $378.4M | $321.3M | $235.7M | $214.5M |
| Total Current Assets | $1.98B | $1.54B | $1.94B | $1.92B | $1.74B | $1.37B | $1.06B | $894.4M |
| Property, Plant & Equipment | $1.73B | $1.58B | $1.41B | $1.16B | $1.06B | $943.2M | $839.3M | $822.0M |
| Goodwill | $109.9M | $106.0M | $108.5M | $107.3M | $109.9M | $111.1M | $107.8M | $105.8M |
| Intangible Assets (Excl. Goodwill) | $7.7M | $10.8M | $15.1M | $18.4M | $23.0M | $30.5M | $29.8M | $20.3M |
| Total Assets | $4.27B | $3.64B | $3.83B | $3.62B | $3.31B | $2.79B | $2.34B | $1.98B |
| Liabilities | ||||||||
| Accounts Payable | $253.7M | $239.3M | $242.4M | $215.4M | $232.2M | $213.1M | $156.8M | $130.4M |
| Total Current Liabilities | $654.9M | $550.4M | $671.8M | $519.0M | $594.1M | $503.4M | $341.6M | $283.7M |
| Long-Term Debt | $202.8M | $202.6M | $72.8M | $206.7M | $208.8M | $252.9M | $255.0M | $196.0M |
| Total Liabilities | $1.09B | $961.1M | $948.5M | $931.9M | $978.4M | $939.3M | $768.2M | $582.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $4.37B | $3.96B | $3.52B | $2.99B | $2.46B | $1.85B | $1.55B | $1.35B |
| Total Stockholders' Equity | $3.18B | $2.68B | $2.88B | $2.68B | $2.34B | $1.85B | $1.57B | $1.40B |